Kei Takuma
Kagawa University
42 Papers
10 Citations
Kei Takuma is an academic researcher from Kagawa University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 14 publications.
Chat about Author
Papers
Effect of pegylated interferon alfa-2a in HBeAg-negative chronic hepatitis B during and 48 weeks after off-treatment follow-up: the limitation of pre-treatment HBsAg load for the seroclearance of HBsAg
Shima Mimura,Koji Fujita,Kei Takuma,Mai Nakahara,Kyoko Oura,Tomoko Tadokoro,Hideki Kobara,Joji Tani,Asahiro Morishita,Takashi Himoto,Tsutomu Masaki +10 more
TL;DR: In this article, the efficacy of pegylated interferon (Peg-IFN) alfa-2a treatment for seroclearance of HBs antigen (HBsAg) in HBe antigen (HBeAg)-negative chronic hepatitis B (CHB) patients was evaluated.
24
Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study
Asahiro Morishita,Kyoko Oura,Kei Takuma,Mai Nakahara,Tomoko Tadokoro,Koji Fujita,Joji Tani,Tingting Shi,Takashi Himoto,Miwa Tatsuta,Akio Moriya,Tomonori Senoo,Akemi Tsutsui,Takuya Nagano,Koichi Takaguchi,Masafumi Ono,Tsutomu Masaki +16 more
TL;DR: In this article , the effect of pemafibrate treatment on liver function and fibrosis by liver function tests (LFTs) and various fibrotic biomarkers including FibroScan in non-alcoholic fatty liver disease (NAFLD) with hypertriglyceridemia.
Antihypertensive drug telmisartan suppresses the proliferation of gastric cancer cells in vitro and in vivo.
Naoki Fujita,Koji Fujita,Hisakazu Iwama,Hideki Kobara,Shintaro Fujihara,Taiga Chiyo,Daisuke Namima,Hiroki Yamana,Toshiaki Kono,Kei Takuma,Masahiro Hirata,Kiyoyuki Kobayashi,Kiyohito Kato,Hideki Kamada,Asahiro Morishita,Kunihiko Tsutsui,Takashi Himoto,Keiichi Okano,Yasuyuki Suzuki,Tsutomu Masaki +19 more
TL;DR: It was shown here that telmisartan suppressed the proliferation of the cultured human gastric cancer cell lines MKN74, MKN1 and MKN45 as detected in the CCK‑8 assay.
Usefulness of the Measurement of Psoas Muscle Volume for Sarcopenia Diagnosis in Patients with Liver Disease
Takushi Manabe,Chikara Ogawa,Kei Takuma,Mai Nakahara,Kyoko Oura,Tomoko Tadokoro,Koji Fujita,Joji Tani,Mitsushige Shibatoge,Asahiro Morishita,Masatoshi Kudo,Tsutomu Masaki +11 more
TL;DR: In this paper , the psoas muscle volume index (PMVI) was determined using one of the diagnostic methods as the gold standard for sarcopenia, and the cutoff value of the PMVI was determined by using the SYNAPSE 3D software.
12
Long-Term Outcomes and Evaluation of Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Eradication by Direct-Acting Antiviral Treatment: All Kagawa Liver Disease Group (AKLDG) Study.
Joji Tani,Tomonori Senoh,Akio Moriya,Chikara Ogawa,Akihiro Deguchi,Teppei Sakamoto,Kei Takuma,Mai Nakahara,Kyoko Oura,Tomoko Tadokoro,Shima Mimura,Koji Fujita,Hirohito Yoneyama,Hideki Kobara,Asahiro Morishita,Takashi Himoto,Akemi Tsutsui,Takuya Nagano,Koichi Takaguchi,Tsutomu Masaki +19 more
TL;DR: In this article, the authors investigated the recurrence rates, recurrence factors, and prognosis of 130 patients who were treated with IFN-free DAA treatment after treatment for hepatocellular carcinoma (HCC).
6